Literature DB >> 2289007

Buprenorphine responders.

L Mongan, E Callaway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2289007     DOI： 10.1016/0006-3223(90)90619-d

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  4 in total

1.  Opioidergic Agents as Antidepressants: Rationale and Promise.

Authors:  Parnika P Saxena; J Alexander Bodkin
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

2.  Evaluation of opioid modulation in major depressive disorder.

Authors:  Elliot Ehrich; Ryan Turncliff; Yangchun Du; Richard Leigh-Pemberton; Emilio Fernandez; Reese Jones; Maurizio Fava
Journal:  Neuropsychopharmacology       Date:  2014-12-18       Impact factor: 7.853

Review 3.  Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches.

Authors:  Marta Peciña; Jordan F Karp; Sanjay Mathew; Mark S Todtenkopf; Elliot W Ehrich; Jon-Kar Zubieta
Journal:  Mol Psychiatry       Date:  2018-06-28       Impact factor: 15.992

4.  Opioid antagonists are associated with a reduction in the symptoms of schizophrenia: a meta-analysis of controlled trials.

Authors:  Samuel D Clark; Jared X Van Snellenberg; Jacqueline M Lawson; Anissa Abi-Dargham
Journal:  Neuropsychopharmacology       Date:  2020-06-09       Impact factor: 7.853
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.